Indian pharmaceutical giant Wockhardt is putting itself up for grabs. The company, known for its wide range of generic and branded pharmaceuticals, has been facing difficulties in recent years. Sources close to the transaction suggest that Wockhardt is {attracting interest from|being courted by both